The Pfizer Foundation has announced 20 grants to help non-governmental organizations (NGOs), non-profits and social ente...
Orphan drugs market analysis considers sales from both biologics and non-biologics. The analysis also considers the sale...
The global single-use filtration assemblies market size is expected to reach USD 7.0 billion by 2026 and is pr...
As per the report, the global molecular imaging market analysis conducted by BIS Research, the market was valued at appr...
AstraZeneca, on 20 August 2019, announced positive results from the landmark Phase III DAPA-HF trial which showed that&n...
The U.S. Food and Drug Administration, on 19 August 2019, approved Xenleta (lefamulin) to treat adults with community-ac...
Moderna, Inc.,a clinical stage biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create...
David Rhew, M.D., has joined Microsoft's Worldwide Commercial Business (WCB) Healthcare leadership team as the Chief Med...
Boston Scientific Corporation has announced the completion of its acquisition of BTG plc. pursuant to the previousl...
Merck, a leading science and technology company, on 19th August 2019, announced that the European, Israeli, South Korean...
IDTechEx, a market intelligence and events company focused on emerging technologies, reports that the market for 3D prin...
Pretomanid, a novel compound developed by the non-profit organization TB Alliance, was approved by the U.S. Food & D...
Medtronic has announced U.S. Food and Drug Administration (FDA) approval of the EvolutTM Transcathe...
The U.S. Food and Drug Administration has approved the first spinal tether device intended to be used in children and ad...
Celgene Corporation has announced the U.S. Food and Drug Administration (FDA) has approved INREBIC® (fedra...
AbbVie, a research-based global biopharmaceutical company, has announced that the U.S. Food and Drug Administratio...
CureVac AG, a fully integrated Germany based biopharmaceutical company pioneering the field of mRNA-based drugs, announc...
BioIVT, a leading provider of research models and services for drug and diagnostic development, on 15 August 2019, annou...
